Global qPCR Market 2017-2021
PCR is a technique of molecular genetics, used for precise, specific, and accurate amplification and analysis of nucleic acid sequences. It is also used in a wide range of applications in research and diagnosis, such as genetic engineering, cloning, gene expression, sequencing, diagnosis, and genotyping. The two widely accepted technologies of PCR in the areas of research and diagnosis are quantitative polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR). Types of PCR technology (%) and biotechnology companies. The qPCR mainly gives accurate results within a very short time.
Technavio’s analysts forecast the global qPCR market to grow at a CAGR of 7.63% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global qPCR market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the qPCR instrument.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global qPCR Market 2017-2021
Technavio recognizes the following companies as the key players in the global qPCR market: Agilent Technologies, Bio-Rad Laboratories, QIAGEN, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: altona Diagnostics, Cepheid, Roche Diagnostics, Promega, and TATAA Biocenter.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increase in M&A. The vendors are competing for incorporating the latest technology in their product portfolio. The pace of technological innovation has slowed down in this market, which made difficult for the small and medium players to survive in the market with the consistent financial record. Even the big players are facing challenges to sustain with satisfactory profit margins.”
According to the report, one of the major drivers for this market is rise in geriatric population. The growing life expectancy and declining fertility rates across many countries in the world, especially in Europe and the Americas, has resulted in the rise of the median age of the population. This has resulted in a relatively higher number of older people in these regions. The number of people above the age of 60 years almost tripled from 200 million in 1950 to over 600 million in 2000. The UN projects this number to touch two billion by 2050.
Further, the report states that one of the major factors hindering the growth of this market is high pricing of products. The technological aspects and legality for qPCR system approvals involve high expenses, which means the qPCR products become costly. Most of the end-users such as research laboratories, academic institutes, and clinical research organizations have limited budgets, and sometimes research grants are very less, which limits the affordability of qPCR instruments and services.
Agilent Technologies, Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, altona Diagnostics, Cepheid, Roche Diagnostics, Promega, and TATAA Biocenter.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook